Orthofix Capital Surpluse from 2010 to 2024

OFIX Stock  USD 19.13  0.21  1.09%   
Orthofix Medical Capital Surpluse yearly trend continues to be fairly stable with very little volatility. Capital Surpluse will likely drop to about 280.6 M in 2024. During the period from 2010 to 2024, Orthofix Medical Capital Surpluse regression line of annual values had r-squared of  0.62 and arithmetic mean of  261,232,297. View All Fundamentals
 
Capital Surpluse  
First Reported
2011-06-30
Previous Quarter
335 M
Current Value
721.1 M
Quarterly Volatility
77.6 M
 
Yuan Drop
 
Covid
Check Orthofix Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orthofix Medical's main balance sheet or income statement drivers, such as Interest Expense of 9.1 M, Total Revenue of 784 M or Gross Profit of 259.2 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0 or PTB Ratio of 0.79. Orthofix financial statements analysis is a perfect complement when working with Orthofix Medical Valuation or Volatility modules.
  
Check out the analysis of Orthofix Medical Correlation against competitors.
For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.

Latest Orthofix Medical's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Orthofix Medical over the last few years. It is Orthofix Medical's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Orthofix Medical's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Orthofix Capital Surpluse Regression Statistics

Arithmetic Mean261,232,297
Geometric Mean256,918,775
Coefficient Of Variation19.77
Mean Deviation41,414,889
Median243,165,000
Standard Deviation51,655,647
Sample Variance2668.3T
Range181.1M
R-Value0.79
Mean Square Error1083.6T
R-Squared0.62
Significance0.0005
Slope9,116,128
Total Sum of Squares37356.3T

Orthofix Capital Surpluse History

2024280.6 M
2023385.2 M
2022335 M
2021314 M
2020292.3 M
2019271 M
2018243.2 M

About Orthofix Medical Financial Statements

Orthofix Medical investors use historical fundamental indicators, such as Orthofix Medical's Capital Surpluse, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Orthofix Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse385.2 M280.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.